Skip to content

MDCXW MEDICUS PHARMA LTD

Follow

*W EXP 11/15/202 (warrant or right), issuer CIK 1997296

5 managers (5 13F filers) reported a position in MDCXW shares at 2025-09-30, 170,203 shares in all. 0 filers opened a position and 0 filers sold out during the quarter.

Managers
5
13F filers
5
New
0
Added
1
Reduced
1
Sold out
0
Shares held by filers
170,203

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2025

Filers in the available 13F reports with a share position at 2025-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Anson Funds Management LPin group Anson Funds Management LP42,400$98.2K0.01%013F-HRTimelineGroup
ARMISTICE CAPITAL, LLC60,600$43.6K<0.01%013F-HRTimeline
Private Advisor Group, LLC44,000$31.7K<0.01%+5,00013F-HRTimeline
Warberg Asset Management LLC17,203$12.4K<0.01%-42,40813F-HRTimeline
Connective Capital Management, LLC6,000$4.32K<0.01%013F-HRTimeline